| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 01/24/2008 | WO2007094819A3 Triazole compounds that modulate hsp90 activity |
| 01/24/2008 | WO2007001975A8 Piperidine derivatives useful as histamine h3 antagonists |
| 01/24/2008 | US20080021222 Reacting an organic amine compound with a carbamyl-group-containing amide compound in the presence of a suitable polar or nonpolar aprotic, substantially anhydrous solvent or mixtures thereof; used as therapeutic agents for IMPDH-mediated diseases |
| 01/24/2008 | US20080021217 Heterocyclic inhibitors of rho kinase |
| 01/24/2008 | US20080021215 Reacting 3-fluoro-4-morpholinyl aniline derivative with epichlorohydrin; converting chloromethyl oxazolidinone to aminomethyl oxazolidinone; carbonylation ; reacting with potassium phthalimide, hydrazine hydrate, and acetic anhydride; cyclization, carbamylation; antibacterial agent |
| 01/24/2008 | US20080021214 Novel process for the preparation of linezolid and related compounds |
| 01/24/2008 | US20080021213 Intermediates for oxazolidinone antibacterials; N-[3-Chloro-2-(R)-hydroxypropyl]-3-fluoro-4-morpholinyl aniline |
| 01/24/2008 | US20080021180 Chromium catalysts active in olefin polymerization |
| 01/24/2008 | US20080021079 Compounds, Compositions, and Methods |
| 01/24/2008 | US20080021071 3-{4-(Pyridin-3-Yl) Phenyl}-5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents |
| 01/24/2008 | US20080021053 Heterocyclic Derivatives |
| 01/24/2008 | US20080021030 Substituted Pyrazoles As Ppar Agonists |
| 01/24/2008 | US20080021029 Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors |
| 01/24/2008 | US20080021028 ((2S,3S) N,2-dihydroxy-5-methyl-3-{[4-(2-pyridinyl)-1-piperazinyl]carbonyl}hexanamide; for treatment and/or prevention of disorders related to autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, stroke, cancer, pre-term labor, endometriosis |
| 01/24/2008 | US20080021027 Novel benzimidazole derivatives |
| 01/24/2008 | US20080021025 Inhibitors of cathepsin s |
| 01/24/2008 | US20080021022 (5-(4-Chlorophenyl)isoxazol-4-yl)(3-(pyridin-3-yl)pyrrolidin-1-yl)methanone; enzyme inhibitor of Hydroxysteroid dehydrogenases; treatment of diabetes, obesity |
| 01/24/2008 | US20080021012 3-[4-{6-Substituted Alkanoyl Pyridin-3-Yl}-3-Phenyl]-5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones As Antibacterial Agents |
| 01/24/2008 | US20080021011 Therapeutic compounds |
| 01/24/2008 | US20080021010 2,4-dichloro-N-{[1- (propylsulfonyl)-3-pyridin-2- ylazetidin-3- yl]methyl}benzamide; neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunction |
| 01/24/2008 | US20080021009 1,2,4-Oxadiazole Derivatives as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes |
| 01/24/2008 | US20080019915 including cystic fibrosis transmembrane conductance regulator ("CFTR"); N[6-(2-hydroxymethylphenyl-1yl)-5-methylpyrimidine][(4-methoxophenyl-1-yl)cyclopopyl]-amide; genetic disorders; respiratory system disorders, cystic fibrosis, hereditary emphysema and hemochromatosis, coagulation-fibrinolysis |
| 01/24/2008 | US20080017846 1,3-Bis[2-(2,2'-bipyridin-6-yl)-1,3,4-oxadiazol-5-yl]benzene; excellent electron injecting and transporting performances and hole blocking ability; high stability in a thin film state; high efficiency and high durability; organic electroluminescent devices |
| 01/24/2008 | US20080016674 Method And Installation Means For Installing An Electrical Machine |
| 01/24/2008 | CA2659524A1 Novel chromene and thiochromene carboxamide derivatives, methods for preparing same and therapeutic applications of same |
| 01/24/2008 | CA2659155A1 Substituted azole aromatic heterocycles as inhibitors of 11.beta.-hsd-1 |
| 01/24/2008 | CA2658573A1 Cgrp receptor antagonists |
| 01/24/2008 | CA2658190A1 Di-amino-substituted heterocyclic compounds and methods of use |
| 01/24/2008 | CA2657850A1 Novel pyridazine derivatives |
| 01/24/2008 | CA2657776A1 Triazolyl phenyl benzenesulfonamides |
| 01/24/2008 | CA2657280A1 Macrocyclic compounds useful as bace inhibitors |
| 01/24/2008 | CA2657258A1 Amino-piperidine derivatives as cetp inhibitors |
| 01/24/2008 | CA2656715A1 Compounds and compositions as itpkb inhibitors |
| 01/24/2008 | CA2644047A1 Heterobicyclic carboxamides as inhibitors for kinases |
| 01/23/2008 | EP1880995A1 Method for producing indole derivative having piperidine ring |
| 01/23/2008 | EP1879904A1 4" amino linked macrolides useful for the treatment of microbial infections |
| 01/23/2008 | EP1879887A2 Npy antagonists, preparation and use |
| 01/23/2008 | EP1879884A1 Azole-based phosphodiesterase inhibitors |
| 01/23/2008 | EP1879882A1 3 -m0n0- and 3 , 5-disubstituted piperidine derivatives as renin inhibitors |
| 01/23/2008 | EP1879881A2 Inhibitors of 11-beta hydroxysteroid dehydrogenase type i |
| 01/23/2008 | EP1879879A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 01/23/2008 | EP1879858A2 Processes for preparing biaryl ureas and analogs thereof |
| 01/23/2008 | EP1879573A1 Modulators of indoleamine 2,3-dioxygenase and methods of using the same |
| 01/23/2008 | EP1773825B1 Dioxazinyl-substituted thienylsulphonylaminocarbonyl compounds |
| 01/23/2008 | EP1725232B1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor |
| 01/23/2008 | EP1667635A4 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 01/23/2008 | EP1636215B1 Furazanobenzimidazoles |
| 01/23/2008 | EP1569934B1 Cyclopropyl compounds as ccr5 antagonists |
| 01/23/2008 | EP1432313B1 N-thio-nicotinamide derivatives and related compounds for use as pesticides |
| 01/23/2008 | EP1322619B1 Isoquinolinone potassium channel inhibitors |
| 01/23/2008 | EP1272178B1 Bilirubin or biliverdin degradation fragments |
| 01/23/2008 | EP1257547B1 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 01/23/2008 | EP1020465B1 Stereoisomeric indole compounds, process for the preparation of the same, and use thereof |
| 01/23/2008 | EP0812321B1 Prokinetic oxadiazoles |
| 01/23/2008 | CN101111488A Novel compounds |
| 01/23/2008 | CN101111486A 抗糖尿病二环化合物 Antidiabetic bicyclic compound |
| 01/23/2008 | CN101111247A Preventive or therapeutic agent for herpesvirus-related disease |
| 01/23/2008 | CN101108849A Benzo**azine compound having crystal structure and method of producing the same |
| 01/23/2008 | CN101108830A Cyclic compound, process for producing the same, and pest control agent |
| 01/23/2008 | CN100363361C Hetaryl-substd. heterocycles |
| 01/23/2008 | CN100363348C PgD2 receptor antagonists for the treatment of inflammatory diseases |
| 01/23/2008 | CN100363346C Small molecular inhibiting agent for coronavirus main proteinase, its preparation method and uses |
| 01/22/2008 | US7321063 Sulfonamide inhibitors of aspartyl protease |
| 01/22/2008 | US7320995 Lung melanoma metastasis, rheumatoid arthritis, 1-isopropylsulfonyl-2-amino-6-(2-(2,6-difluorophenyl)-5-(phenyl)-imidazol-4-yl)-benzimidazole |
| 01/22/2008 | US7320994 {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chloro-phenyl)-methanone; anxiety, depression, psychosis, and schizophrenia and other psychotic disorders; neurodegenerative disorders, multiple sclerosis and amyotrophic lateral sclerosis |
| 01/22/2008 | US7320993 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents |
| 01/22/2008 | US7320989 E.g., {4-Chloro-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)ethoxy]phenyl}-(2-methylquinolin-4-yl)amine; congestive heart failure, stroke, antiischemic, -arrhythmia, -arthritis, -diabetic, -inflammatory, -ulcer and hypotensive agents; urogenital, bone, respiratory, cardiovascular and nervous systems disorders |
| 01/22/2008 | US7320978 Inflammations of the respiratory system, locomotor system traumas, and edemas; 1-{[5-(4-Chlorophenyl)-4-(2,4-dichlorophenyl)-1,3-oxazol-2-yl]carbonyl}-4-(3-methylphenyl)piperazine |
| 01/22/2008 | US7320973 5,11-Dihydrodiaryl[b,e][1,4,]oxazepine derivatives for gastrointestinal disorder treatment; irritable bowel syndrome |
| 01/22/2008 | CA2305807C Substituted fused heterocyclic compounds |
| 01/22/2008 | CA2281721C Phthalazines with angiogenesis inhibiting activity |
| 01/17/2008 | WO2008008518A1 Substituted diazepan orexin receptor antagonists |
| 01/17/2008 | WO2008008327A2 Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound |
| 01/17/2008 | WO2008008022A1 Isoindoline derivatives for the treatment of arrhythmias |
| 01/17/2008 | WO2008007390A2 An improved process for purification of zolmitriptan |
| 01/17/2008 | WO2008006795A2 Indole compounds |
| 01/17/2008 | WO2008006794A1 Indole compounds having affinity to the ep1 receptor |
| 01/17/2008 | WO2008006793A1 Indole compounds |
| 01/17/2008 | WO2008006790A1 Indole compounds |
| 01/17/2008 | WO2008006583A1 Pyrimidine derivatives as alk-5 inhibitors |
| 01/17/2008 | WO2008006561A1 Substituted isoxalines, pharmaceutical compositions containing same, methods of preparing same, and uses of same |
| 01/17/2008 | WO2008006560A1 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 01/17/2008 | WO2008006479A1 2-(heteroaryl) alkyl indazole 6-phenyl and thienyl methyl amide as thrombin inhibitors |
| 01/17/2008 | WO2008006372A1 (3-aryl-piperazin-1-yl), (2-aryl-morpholin-4-yl) and (2-aryl- thiomorpholin-4-yl) derivatives of 6,7-dialkoxyquinazoline, 6,7- dialkoxyphtalazine and 6,7-dialkoxyisoquinoline |
| 01/17/2008 | WO2007084413B1 Methods for treating hepatitis c |
| 01/17/2008 | WO2007074078A3 Aryl-isoxazol-4-yl-imidazole derivatives |
| 01/17/2008 | WO2007019080A3 Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/17/2008 | WO2006056930A3 Novel 4 -aminopiperidine derivatives as plasmepsin ii inhibitors |
| 01/17/2008 | US20080015242 Use of N-[3-[2-[2-(3-methylindazol-6-yloxy)ethylamino]-1-hydroxyethyl]phenyl]methanesulfonamide or salt for treating diabetes, obesity, hyperlipidemia and urinary incontinence; drug interaction side effect reduction |
| 01/17/2008 | US20080015238 Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticals |
| 01/17/2008 | US20080015237 New compounds i/418 |
| 01/17/2008 | US20080015234 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 01/17/2008 | US20080015233 2,4,6-Substituted Pyridyl Derivative Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease |
| 01/17/2008 | US20080015232 Schweinfurthin analogues |
| 01/17/2008 | US20080015225 Dimeric Piperidine Derivatives |
| 01/17/2008 | US20080015204 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 01/17/2008 | US20080015203 Such as 3-[(1S)-2-hydroxy-1-methylethoxy]-5-[4-(methylsulfonyl)phenoxy]-N-1,3-thiazol-2-ylbenzamide; glucokinases (Glk) |
| 01/17/2008 | US20080015192 Inhibitors of polo-like kinases |
| 01/17/2008 | US20080015191 Pyrazines and Pyridines and Derivatives Thereof as Therapeutic Compounds |
| 01/17/2008 | US20080015190 Inhibitors of Histone Deacetylase |